已收盘 05-08 16:00:00 美东时间
+0.320
+0.45%
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
Mizuho analyst Steven Valiquette maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $88 to $82.
05-06 21:46
U.S. RESEARCH ROUNDUP-IBM, Lumentum Holdings, TransDigm Group May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including IBM, Lumentum Holdings and TransDigm Group, on Wednesday. HIGHLIGHTS * Advanced Micro Devices AMD.O : Ev
05-06 15:13
华盛资讯5月6日讯,亨利香恩服务公布2026财年Q1业绩,公司Q1营收33.68亿美元,同比增长6.3%,归母净利润1.07亿美元,同比下滑2.7%。
05-06 01:32
华盛资讯5月5日讯,亨利香恩服务公布2026财年Q1业绩,公司Q1营收33.68亿美元,同比增长6.3%,归母净利润1.07亿美元,同比下滑2.7%。
05-05 21:38
On Tuesday, Henry Schein (NASDAQ:HSIC) discussed first-quarter financial result...
05-05 21:02
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Henry Schein (NASDAQ:HSIC) affirms FY2026 Adj EPS guidance from $5.23-$5.37 to $5.23-$5.37 vs $5.32 analyst estimate. Affirms FY2026 sales outlook from $13.580 billion-$13.843 billion to $13.580 billion-$13.843 billion
05-05 18:02
BRIEF-Henry Schein Q1 Adjusted EPS USD 1.32 Vs. IBES Estimate USD 1.22 May 05 (Reuters) - Henry Schein Q1 EPS USD 0.92. Q1 sales USD 3,400 million vs. IBES estimate USD 3,342 million Q1 net income USD 107 million Q1 adjusted net income USD 153 million vs. IBES estimate USD 142.5 million outlook FY a
05-05 18:00
Henry Schein presents at Bank of America Healthcare Conference in May Henry Schein scheduled to present at Bank of America Healthcare Conference in Las Vegas on May 13 at 2:20 p.m. Pacific time. Presentation also set for Stifel Jaws & Paws Conference in New York on May 27 at 3:00 p.m. Eastern time.
05-04 18:30